4.5 Review

Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities

Journal

JHEP REPORTS
Volume 2, Issue 6, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.jhepr.2020.100165

Keywords

Purinergic signals; Liver; Adenosine receptors; Nucleotide receptors; Ectonucleoside triphosphate diphosphohydrolases 1; Ecto-5 '-nucleotidase

Funding

  1. National Natural Science Foundation of China [81870399, 81770598]
  2. National Science and Technology Major Special Project for New Drug Development [2018ZX09201016]

Ask authors/readers for more resources

Extracellular nucleotides, including ATP, are essential regulators of liver function and serve as danger signals that trigger inflammation upon injury. Ectonucleotidases, which are expressed by liver-resident cells and recruited immune cells sequentially hydrolyse nucleotides to adenosine. The nucleotide/nucleoside balance orchestrates liver homeostasis, tissue repair, and functional restoration by regulating the crosstalk between liver-resident cells and recruited immune cells. In this review, we discuss our current knowledge on the role of purinergic signals in liver homeostasis, restriction of inflammation, stimulation of liver regeneration, modulation of fibrogenesis, and regulation of carcinogenesis. Moreover, we discuss potential targeted therapeutic strategies for liver diseases based on purinergic signals involving blockade of nucleotide receptors, enhancement of ectonucleoside triphosphate diphosphohydrolase activity, and activation of adenosine receptors. (C) 2020 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available